Becoming a patient advocate teaches us that our pain has a purpose.
By Paul Demko 03/02/2018 04:20 PM EDT Patients with severe, often life-threatening illnesses could see steep and unexpected drug costs in the coming weeks due to an arcane change in the way many insurers handle drug maker discounts. At issue are coupons that pharmaceutical companies provide for pricey treatments for diseases like cancer, HIV, hepatitis […]
Pfizer offers a patient-friendly explanation of biosimilars – what they are, how they differ from generics, and how they are developed and approved, among other topics on the company’s biosimilars website. Read more.
By 2020, the global biosimilars market is expected to top $390 billion and account for up to 28 percent of the global market for pharmaceuticals, due in large part to the loss of patent protection for commercially successful drugs. Read more.
In an analysis of step therapy regulations, GHLF looked at every state bill currently related to step therapy and scored them on how strongly they protected patients on a scale from one to 10. You can also see whether your state has passed or has pending legislation relating to step therapy protocols. Read more.